RT Book, Section
A1 Smith, Silas W.
A1 Geyer, Howard L.
A2 Nelson, Lewis S.
A2 Howland, Mary Ann
A2 Lewin, Neal A.
A2 Smith, Silas W.
A2 Goldfrank, Lewis R.
A2 Hoffman, Robert S.
SR Print(0)
ID 1163001974
T1 Botulinum Antitoxin
T2 Goldfrank's Toxicologic Emergencies, 11e
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9781259859618
LK accesspharmacy.mhmedical.com/content.aspx?aid=1163001974
RD 2024/04/20
AB Antidotal  therapies  for  adult  and  infant  Clostridium  botulinum  infection  are  available  as  equine-  and  human-derived  immunoglobulin  antitoxins.  Antitoxins  are  beneficial  for  most  clinical  forms  of  botulism,  although  their  utility  is  restricted  to  limiting  disease  progression  rather  than  to  reversing  clinical  manifestations.